LivaNova (LIVN) FCF Margin Growth (5y) (2021 - 2026)
LivaNova (LIVN) FCF Margin Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn |
| 10 | LivaNova | 4.37 Bn | 3.83 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -324.00 |
| Dec 31, 2025 | 262.00 |
| Sep 30, 2025 | 1,814.00 |
| Jun 30, 2025 | 2,913.00 |
| Mar 31, 2025 | 5,145.00 |
| Dec 31, 2024 | 2,297.00 |
| Sep 30, 2024 | 4,107.00 |
| Jun 30, 2024 | 1,861.00 |
| Mar 31, 2024 | 272.00 |
| Dec 31, 2023 | 1,053.00 |
| Sep 30, 2023 | -1,113.00 |
| Jun 30, 2023 | -1,551.00 |
| Mar 31, 2023 | -85.00 |
| Dec 31, 2022 | 34.00 |
| Sep 30, 2022 | -143.00 |
| Jun 30, 2022 | -292.00 |
| Mar 31, 2022 | -272.00 |
| Dec 31, 2021 | -298.00 |
| Sep 30, 2021 | -210.00 |
| Mar 31, 2021 | 390.00 |